Efficacy of mast cell directed therapies in irritable bowel syndrome: a systematic review

CONCLUSIONS: Mast cell modulating therapies could be of significant value in therapy for IBS patients. Further high-quality research is needed to establish the therapeutic efficacy of mast cell targeted therapies in order to draw robust conclusions and improve the clinical management of irritable bowel syndrome.PMID:38431786 | DOI:10.51821/87.1.12487
Source: Acta Gastro-Enterologica Belgica - Category: Gastroenterology Authors: Source Type: research